Marti Jett-Tilton

Title: Marti Jett-Tilton: Innovator in Biotechnology

Introduction

Marti Jett-Tilton is a notable inventor based in Washington, DC. She has made significant contributions to the field of biotechnology, particularly in the treatment of diseases through innovative compositions. With a total of 2 patents, her work has the potential to impact cancer and viral disease therapies.

Latest Patents

Marti's latest patents include groundbreaking research on phosphatidyl treatment of rapidly proliferating cells. This patent describes diacyl phosphatides that exhibit cytotoxic effects against tumor cells. The subject compositions can be utilized in vivo or in vitro to inhibit tumor cell growth, either alone or in combination with other cytotoxic drugs. These compositions may be administered as liposomes. Another significant patent focuses on the phosphatidyl treatment of viral diseases. This research demonstrates that phosphatides possess antiviral activity, particularly against retroviruses. By contacting cells that are susceptible to or infected with a virus, the proliferation of the virus can be substantially inhibited.

Career Highlights

Throughout her career, Marti has worked with various organizations, including Houston Biotechnology Incorporated and the U.S. Government as represented by the Secretary of the Army. Her expertise in biotechnology has allowed her to contribute to important research and development projects.

Collaborations

Marti has collaborated with notable professionals in her field, including Carl R. Alving. Their joint efforts have further advanced the understanding and application of phosphatidyl treatments in medical science.

Conclusion

Marti Jett-Tilton's innovative work in biotechnology showcases her dedication to improving health outcomes through her patented inventions. Her contributions to the treatment of cancer and viral diseases highlight the importance of research and innovation in the medical field.